Biomedical subjects
S M Enright
Publications and source records attributed to S M Enright.
Quality and outcome: pharmacy's professional imperative.
Societal forces behind the increased use of outcomes to measure the quality of health care are described, and continuous improvement of outcomes as a goal for pharmacy is discussed. Consumerism, the demands of the aging American population, and problems of access to care for many Americans have helped to bring about an examination of quality. The effectiveness of clinical decision-making methods has been challenged. The Joint Commission on Accreditation of Healthcare Organizations now seeks to examine whether quality care is being provided, rather than whether the capacity exists to provide it. Inspection against criteria to determine quality will be superseded by a goal of continuous improvement. Traditional drug-use evaluation needs to go beyond collection of data and confrontation of noncompliant prescribing. Multidisciplinary quality improvement efforts should focus on patient outcomes; the goal should be to prevent all errors, rather than to not exceed some tolerable rate of errors. Pharmacists and risk managers should share information. Documentation of quality assurance efforts will be required. Drug-use evaluations should include assessment for therapeutic failure. Pharmacy quality improvement efforts can improve patient care and expand the pharmacist's role on the health-care team.
Pharmacists as principal investigators in clinical drug research.
Explore the source record for details and available documents.
Managed care: doomed to succeed?
Explore the source record for details and available documents.
Hospital staff reductions.
Explore the source record for details and available documents.
Productivity and incentives.
Explore the source record for details and available documents.
Assessing patient outcomes.
Explore the source record for details and available documents.
Preferred providers.
Explore the source record for details and available documents.
Mail-order pharmaceuticals.
Explore the source record for details and available documents.
Relapse in health-care costs.
Explore the source record for details and available documents.
Technologic innovation.
Explore the source record for details and available documents.
Health care's safety net.
Explore the source record for details and available documents.
Unions' interest in health care.
Explore the source record for details and available documents.
New concerns in risk management.
Explore the source record for details and available documents.
Evolving strategies for joint ventures.
Explore the source record for details and available documents.
Emerging alternative delivery systems for pharmaceuticals.
Explore the source record for details and available documents.
Health-care marketing.
Explore the source record for details and available documents.